Erkang Pharmaceuticals: 300267 Erkang Pharmaceutical Investor Relations Management Information 20241010
Erkang Pharmaceutical: Announcement on participating in the 2024 Online Group Reception Day for Investors of Listed Companies in Hunan
Erkang Pharmaceuticals: Semi-Annual Report 2024
Erkang Pharmaceuticals: 2024 Semi-Annual Report Summary
Erkang Pharmaceutical: Summary table of non-operating capital expenditure and other related capital transactions for the first half year of 2024
Hunan Er-kang Pharmaceutical: Legal Opinion of Hunan Qiyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Hunan Erkang Pharmaceutical Co., Ltd.
Hunan Er-kang Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hunan Er-kang Pharmaceutical: 300267 Erkang Pharmaceutical Investor Relations Management Information 20240510
Hunan Er-kang Pharmaceutical: 2024 First Quarter Report Disclosure Prompt Announcement
Hunan Er-kang Pharmaceutical: 2024 First Quarter Report
Erkang Pharmaceutical: Resolutions of the First Special Meeting of Independent Directors of the 5th Board of Directors
Erkang Pharmaceutical: Notice on Convening the 2023 Annual General Meeting of Shareholders
Erkang Pharmaceutical: Comparative Table of Amendments to the Articles of Association
Erkang Pharmaceuticals: Annual Report 2023
Erkang Pharmaceuticals: Announcement on changes in accounting policies
Erkang Pharmaceuticals: Announcement on the 2023 Profit Distribution Plan
Erkang Pharmaceutical: Independent Director Tan Xue's 2023 Debriefing Report
Erkang Pharmaceutical: Feasibility Analysis Report on Launching Hedging Business
Erkang Pharmaceuticals: Board of Directors Special Opinions on the Independent Director Assessment
Erkang Pharmaceuticals: 2023 Annual Audit Report
No Data
No Data